Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Plains All American Pipeline, L.P. (Nasdaq: PAA) and its parent Plains GP Holdings reported strong second-quarter 2026 financial results, highlighted by $1.830 billion net income attributable to PAA, including a $1.6 billion gain from the Canadian NGL Business divestiture. The company reduced debt by approximately $2.9 billion, achieving a pro form…
FTI Consulting announces its Compass Lexecon subsidiary has been ranked the top global economic consulting firm on the Lexology Index: Competition 2026 list. The firm had 65 professionals recognized, including 12 named Global Elite Thought Leaders, reflecting its leadership in economic consulting, specifically in competition economics. An additiona…
ACM Research jumped 14.0% in pre-market trading after reporting second-quarter results that outperformed analyst estimates on both earnings and revenue. The company posted EPS of $0.61 versus a $0.42 consensus and revenue of $292.92 million against expectations of $269.24 million, while raising the lower end of its full-year 2026 revenue guidance a…
Corsair Gaming stock rallied sharply in pre-market trading after the company posted second-quarter 2026 results that materially outperformed analyst expectations. The company reported non-GAAP EPS of $0.23 versus a consensus near $0.09, revenue of $314.3 million, and record gross margin of 33.2%. Management also raised the low end of full-year reve…
Guardian Pharmacy Services saw its shares rise in pre-market trading after reporting second-quarter 2026 results that topped analyst expectations on both earnings and revenue. The long-term care pharmacy operator beat consensus adjusted EPS and posted modest year-over-year revenue growth that management said would have been substantially higher abs…
Treace Medical Concepts, a Nasdaq-listed medical technology company specializing in bunion surgical treatments, reported Q2 2026 revenue of $45.4 million, down 4% year-over-year, with a net loss of $15.9 million. The company reduced cash usage by 57% year-to-date and improved adjusted EBITDA loss slightly. It initiated limited releases of new produ…
First Phosphate (FRSPF) is an OTC microcap that has seen a meaningful drop in short interest over the past months while technicals are turning bullish. Coupled with visible short-volume spikes and above-average liquidity for an OTC name, the setup favors a tactical long: a momentum-driven short-covering run could lift the stock through key moving a…
Macerich announced the pricing of $675 million aggregate principal amount of 2.25% exchangeable senior notes due 2031, upsized from a previously announced $600 million. The notes are senior, unsecured obligations of Macerich Partnership and will accrue interest semi-annually. The offering includes a capped call transaction to reduce dilution upon n…
Gyre Therapeutics announced its second quarter 2026 financial results, reporting Q2 revenue of $29.1 million and a GAAP basic loss per share of $0.12. The company affirmed its full-year 2026 revenue guidance of $100.5 to $111.0 million. Key business updates include the acceptance of the NDA for F351 (hydronidone) for chronic hepatitis B-induced liv…
Johnson Outdoors Inc. announced its fiscal third quarter results ending July 3, 2026, reporting a 5% increase in net sales to $189.7 million, driven primarily by strong performance in its Fishing and Diving segments. Operating income more than doubled to $18.3 million aided by tariff refunds, improved margins, and pricing actions. Year-to-date resu…
ARKO Corp., a major U.S. convenience store and fuel wholesaler operator, reported its Q2 2026 results with decreased net income but increased Adjusted EBITDA. The company reaffirmed its full-year Adjusted EBITDA guidance and highlighted progress on transformation initiatives including dealerization, remodels, and loyalty programs. Post-quarter, ARK…
Ultralife Corporation reported second quarter 2026 results featuring $47.9 million in sales, a slight 1.3% revenue decline from the prior year but an improved gross profit margin of 28.9%. The company achieved GAAP EPS of $0.15, tripling from $0.05 in the prior year quarter, and adjusted EBITDA rose 48% to $6.1 million. Backlog hit an all-time high…
Minerva Neurosciences announced progress and financial results for Q2 2026, emphasizing its ongoing global Phase 3 trial of roluperidone for treating negative symptoms of schizophrenia. The company remains on track for topline efficacy data expected in the second half of 2027. Increased R&D and administrative expenses reflect trial activities. The …
NRx Pharmaceuticals announced that the FDA finished the first-cycle review of its ANDA application for preservative-free ketamine, identifying no major deficiencies related to the drug or its manufacturing, labeling, or chemistry. The only remaining issue pertains to packaging certification, specifically the luer lock vial, which is already used in…
Wrap Technologies announced the commercial launch of WrapTactics™, a Learning Management System that completes the training foundation of their WrapShield™ six-tier non-lethal response platform. Following ATF's classification of BolaWrap® 150 as a non-lethal instrument of restraint, WrapTactics™ provides essential training and certification, enabli…
Rapid Micro Biosystems announced its financial results for Q2 2026, showing total revenue of $8.1 million, an 11% growth year-over-year, driven by increased placement and validation of Growth Direct systems. The company achieved record gross margins of 15%, improving significantly from the prior year, and reaffirmed its full-year 2026 revenue guida…
Purple Biotech Ltd. reported strong preclinical results for its tri-specific antibody candidate IM1240, demonstrating favorable anti-tumor activity, safety profile, and pharmacokinetics. The company is preparing for first-in-human clinical studies in 2027. With $6.1 million in cash as of June 30, 2026, Purple Biotech has a runway through mid-2027, …
Sprouts Farmers Market is showing early signs of a sales rebound while retaining high gross margins and strong free cash flow. At roughly $8.1B market cap with EV/EBITDA near 9.5 and a P/E in the high teens, the stock looks reasonably valued for a retailer that still has growth runway from new-store openings and product wins. This trade idea is a t…
GrafTech makes graphite electrodes and needle coke used in electric arc furnace steelmaking and other industrial processes. With commodity-driven cyclicality priced in, the stock's sub-$8 valuation reflects stress rather than a recovery scenario. We lay out a mid-term (45 trading days) entry at $7.64, stop at $6.00 and a $12.00 target tied to an el…
ANI Pharmaceuticals announced strong second-quarter 2026 results with net revenues of $266.0 million, up 25.9% year-over-year, driven mainly by 43.5% growth in Purified Cortrophin Gel sales and a 9.7% increase in generic products. The company reported GAAP net income of $24.7 million and adjusted non-GAAP EBITDA of $71.6 million, up 32.4%. ANI reaf…
Alphatec (ATEC) cratered after a May earnings report that flagged installation timing issues and missed EOS unit deliveries. The stock has stabilized and is showing bullish technicals while trading at a cheaper revenue multiple than the 2025 peak. This is a tactical long: enter on a gentle dip, use a tight stop to respect execution risk, and target…
PENN Entertainment rose in after-hours trading after reporting Q2 2026 adjusted EPS of $0.44, beating the Street by 63%, and posting record retail casino revenues of $1.51 billion. Management narrowed losses in its interactive business and raised full-year 2026 retail EBITDA guidance to a midpoint near $1.963 billion. A flurry of analyst price-targ…
Sweetgreen cut its annual same-store sales guidance after consumer concern over a widespread cyclosporiasis outbreak tied to recalled iceberg lettuce led to weaker demand for fresh produce. The company reiterated it does not use iceberg lettuce and said there is no indication it is linked to the outbreak, while also reporting a continued decline in…
Embecta Corp., a global medical supplies company with a century-long legacy in insulin delivery, has reported its third quarter fiscal 2026 financial results. The company provides detailed earnings information through its investor relations website and has scheduled a live webcast and conference call to discuss the results with analysts and investo…
Nathan's Famous, Inc. reported its first quarter fiscal 2027 results showing increased revenues driven by higher sales volume and price increases, particularly in the branded product segment. Despite a rise in revenue to $54.1 million, net income and earnings per diluted share slightly declined due to increased costs, notably a 22% surge in beef an…
